Archive for ABMN Staff

Meggitt plc (MGGT) Given New GBX 500 Price Target at Jefferies Group

Meggitt plc (MGGT) Given New GBX 500 Price Target at Jefferies Group

Meggitt plc (LON:MGGT) had its target price cut by Jefferies Group from GBX 550 ($7.19) to GBX 500 ($6.54) in a report released on Tuesday. The firm presently has a “hold” rating on the stock. Jefferies Group’s target price would indicate a potential upside of 6.76% from the stock’s previous close. Meggitt plc (LON:MGGT) opened […]
National Express Group PLC (NEX) Given New GBX 405 Price Target at Jefferies Group

National Express Group PLC (NEX) Given New GBX 405 Price Target at Jefferies Group

National Express Group PLC (LON:NEX) had its price objective boosted by investment analysts at Jefferies Group from GBX 370 ($4.84) to GBX 405 ($5.30) in a research note issued on Tuesday. The firm presently has a “buy” rating on the stock. Jefferies Group’s price target would suggest a potential upside of 14.31% from the stock’s […]
Glencore PLC (GLEN) Price Target Lowered to GBX 180 at Jefferies Group

Glencore PLC (GLEN) Price Target Lowered to GBX 180 at Jefferies Group

Glencore PLC (LON:GLEN) had its price target lowered by stock analysts at Jefferies Group from GBX 200 ($2.62) to GBX 180 ($2.35) in a report issued on Tuesday. The brokerage currently has a “hold” rating on the natural resources company’s stock. Jefferies Group’s price objective points to a potential downside of 2.69% from the stock’s […]
South32 Ltd (S32) Rating Reiterated by Jefferies Group

South32 Ltd (S32) Rating Reiterated by Jefferies Group

South32 Ltd (LON:S32)‘s stock had its “hold” rating reaffirmed by analysts at Jefferies Group in a research report issued to clients and investors on Tuesday. They presently have a GBX 110 ($1.44) target price on the stock. Jefferies Group’s price target would indicate a potential downside of 4.05% from the company’s previous close. Shares of […]
Akers Biosciences, Inc. (AKR) Earns “Corporate” Rating from FinnCap

Akers Biosciences, Inc. (AKR) Earns “Corporate” Rating from FinnCap

Akers Biosciences, Inc. (LON:AKR)‘s stock had its “corporate” rating reaffirmed by equities researchers at FinnCap in a research note issued on Tuesday. They presently have a GBX 150 ($1.96) target price on the stock. FinnCap’s target price would suggest a potential downside of 36.07% from the stock’s previous close. Shares of Akers Biosciences (LON:AKR) opened […]
Intec Pharma Ltd (NTEC) Lifted to “Hold” at Zacks Investment Research

Intec Pharma Ltd (NTEC) Lifted to “Hold” at Zacks Investment Research

Intec Pharma Ltd (NASDAQ:NTEC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday. According to Zacks, “Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs through proprietary Accordion Pill platform technology. Its product candidates in clinical trial stages […]
AorTech International plc (AOR) Given Corporate Rating at FinnCap

AorTech International plc (AOR) Given Corporate Rating at FinnCap

AorTech International plc (LON:AOR)‘s stock had its “corporate” rating reiterated by FinnCap in a research report issued on Tuesday. AorTech International plc (LON:AOR) opened at 30.00 on Tuesday. AorTech International plc has a 12-month low of GBX 20.00 and a 12-month high of GBX 43.20. The company’s market capitalization is GBX 1.57 million. The firm’s […]
Great-West Lifeco Inc. (GWO) Plans Quarterly Dividend of C$0.35

Great-West Lifeco Inc. (GWO) Plans Quarterly Dividend of C$0.35

Great-West Lifeco Inc. (TSE:GWO) declared a quarterly dividend on Wednesday, August 31st. Shareholders of record on Friday, September 30th will be paid a dividend of 0.346 per share on Friday, September 30th. This represents a $1.38 annualized dividend and a yield of 4.37%. The ex-dividend date is Wednesday, August 31st. Shares of Great-West Lifeco (TSE:GWO) […]
Bioventix PLC (BVXP) Stock Rating Reaffirmed by FinnCap

Bioventix PLC (BVXP) Stock Rating Reaffirmed by FinnCap

Bioventix PLC (LON:BVXP)‘s stock had its “corporate” rating reissued by stock analysts at FinnCap in a research report issued on Tuesday. They presently have a GBX 1,350 ($17.66) price target on the biotechnology company’s stock. FinnCap’s price target points to a potential upside of 19.47% from the company’s previous close. Bioventix PLC (LON:BVXP) opened at […]
Intellia Therapeutics Inc (NTLA) Stock Rating Upgraded by Zacks Investment Research

Intellia Therapeutics Inc (NTLA) Stock Rating Upgraded by Zacks Investment Research

Intellia Therapeutics Inc (NASDAQ:NTLA) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. According to Zacks, “Intellia Therapeutics, Inc. is a genome editing company focused on the development of curative therapeutics using a biological tool, CRISPR/Cas9 system. Intellia Therapeutics, […]
Byotrol Plc (BYOT) Receives Corporate Rating from FinnCap

Byotrol Plc (BYOT) Receives Corporate Rating from FinnCap

Byotrol Plc (LON:BYOT)‘s stock had its “corporate” rating restated by research analysts at FinnCap in a report issued on Tuesday. They presently have a GBX 6.90 ($0.09) target price on the stock. FinnCap’s price objective points to a potential upside of 43.75% from the company’s previous close. Byotrol Plc (LON:BYOT) opened at 4.80 on Tuesday. […]
Stella-Jones Inc. Plans Quarterly Dividend of C$0.10 (SJ)

Stella-Jones Inc. Plans Quarterly Dividend of C$0.10 (SJ)

Stella-Jones Inc. (TSE:SJ) announced a quarterly dividend on Wednesday, August 31st. Stockholders of record on Friday, September 23rd will be paid a dividend of 0.10 per share on Friday, September 23rd. This represents a $0.40 annualized dividend and a dividend yield of 0.93%. The ex-dividend date is Wednesday, August 31st. Stella-Jones (TSE:SJ) opened at 42.87 […]
FinnCap Reiterates Corporate Rating for Cambridge Cognition Holdings PLC (COG)

FinnCap Reiterates Corporate Rating for Cambridge Cognition Holdings PLC (COG)

Cambridge Cognition Holdings PLC (LON:COG)‘s stock had its “corporate” rating reaffirmed by equities research analysts at FinnCap in a research note issued to investors on Tuesday. They presently have a GBX 100 ($1.31) price target on the stock. FinnCap’s price target indicates a potential upside of 81.82% from the company’s previous close. Shares of Cambridge […]
InVitae Corp (NVTA) Upgraded to “Hold” at Zacks Investment Research

InVitae Corp (NVTA) Upgraded to “Hold” at Zacks Investment Research

InVitae Corp (NASDAQ:NVTA) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Tuesday. According to Zacks, “Invitae Corporation is engaged in genetic diagnostics for hereditary disorders which include breast, colon and pancreatic cancer. It operates primarily in the United States, Israel and internationally. Invitae […]
Dechra Pharmaceuticals plc (DPH) Earns “Under Review” Rating from FinnCap

Dechra Pharmaceuticals plc (DPH) Earns “Under Review” Rating from FinnCap

Dechra Pharmaceuticals plc (LON:DPH)‘s stock had its “under review” rating reaffirmed by equities research analysts at FinnCap in a research report issued to clients and investors on Tuesday. Shares of Dechra Pharmaceuticals plc (LON:DPH) opened at 1337.073730 on Tuesday. The stock has a 50 day moving average of GBX 1,298.08 and a 200-day moving average […]
Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.